Compile Data Set for Download or QSAR
Report error Found 128 of affinity data for UniProtKB/TrEMBL: P01275
TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50244337(trans-4-(((4-tert-butylcyclohexyl)(5,6-dichloro-1-...)
Affinity DataIC50: 3.70E+3nMAssay Description:Binding affinity against human GLP1More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50244265(trans-4-((4-tert-butylcyclohexyl)(1-methyl-6-propo...)
Affinity DataIC50: 5.00E+3nMAssay Description:Binding affinity against human GLP1More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50244236(trans-4-(((4-tert-butylcyclohexyl)(5-(cyclopentylo...)
Affinity DataIC50: 5.00E+3nMAssay Description:Binding affinity against human GLP1More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50244233(trans-4-(((4-tert-butylcyclohexyl)(5-methoxy-1-met...)
Affinity DataIC50: 5.90E+3nMAssay Description:Binding affinity against human GLP1More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50244299(trans-4-(((4-tert-butylcyclohexyl)(1-methyl-5-(tri...)
Affinity DataIC50: 6.80E+3nMAssay Description:Binding affinity against human GLP1More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50244234(trans-4-(((4-tert-butylcyclohexyl)(5-ethoxy-1-meth...)
Affinity DataIC50: 7.60E+3nMAssay Description:Binding affinity against human GLP1More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM2437(US8507533, 157)
Affinity DataKi:  5.55nMAssay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM100827(US8507533, 374 | US8507533, 151 | US8507533, 138)
Affinity DataKi:  5.75nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM100806(US8507533, 115 | US8507533, 330 | US8507533, 114)
Affinity DataKi:  7.60nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM2390(US8507533, 146)
Affinity DataKi:  9.05nMAssay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM142039(US8927577, 35 | US8927577, 118 | US8927577, 20)
Affinity DataKi:  14nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptor. Test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2015
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM100806(US8507533, 115 | US8507533, 330 | US8507533, 114)
Affinity DataKi:  15.8nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM100796(US8507533, 101)
Affinity DataKi:  17nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM2376(US8507533, 137)
Affinity DataKi:  20.2nMAssay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM100827(US8507533, 374 | US8507533, 151 | US8507533, 138)
Affinity DataKi:  20.2nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM142041(US8927577, 22)
Affinity DataKi:  25nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptor. Test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2015
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM100844(US8507533, 398 | US8507533, 160)
Affinity DataKi:  25.7nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM2391(US8507533, 147)
Affinity DataKi:  26.7nMAssay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM100850(US8507533, 168)
Affinity DataKi:  27.4nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM100852(US8507533, 419 | US8507533, 170)
Affinity DataKi:  28nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM100844(US8507533, 398 | US8507533, 160)
Affinity DataKi:  29nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM100822(US8507533, 399 | US8507533, 162 | US8507533, 129)
Affinity DataKi:  29.3nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM2241(US8507533, 136)
Affinity DataKi:  30.2nMAssay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM100838(US8507533, 153)
Affinity DataKi:  32.3nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM160576(US9045389, 8)
Affinity DataKi:  33nM ΔG°:  -39.7kJ/molepH: 7.4 T: 2°CAssay Description:Full-length human GCGR (Accession Number: NM000160) subcloned into pcDNA3.1 was stably transfected into HEK293 cells (hGluc-1 HEK) and maintained und...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2015
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM2240(US8507533, 135)
Affinity DataKi:  35nMAssay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM100837(US8507533, 152)
Affinity DataKi:  35.2nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM160577(US9045389, 9)
Affinity DataKi:  38nM ΔG°:  -39.4kJ/molepH: 7.4 T: 2°CAssay Description:Full-length human GCGR (Accession Number: NM000160) subcloned into pcDNA3.1 was stably transfected into HEK293 cells (hGluc-1 HEK) and maintained und...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2015
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM100805(US8507533, 113)
Affinity DataKi:  38.2nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM142039(US8927577, 35 | US8927577, 118 | US8927577, 20)
Affinity DataKi:  39nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptor. Test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2015
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM2438(US8507533, 158)
Affinity DataKi:  41nMAssay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM100861(US8507533, 188)
Affinity DataKi:  42.2nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM100864(US8507533, 193)
Affinity DataKi:  44.7nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM160575(US9045389, 7)
Affinity DataKi:  45nM ΔG°:  -39.0kJ/molepH: 7.4 T: 2°CAssay Description:Full-length human GCGR (Accession Number: NM000160) subcloned into pcDNA3.1 was stably transfected into HEK293 cells (hGluc-1 HEK) and maintained und...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2015
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM100815(US8507533, 122)
Affinity DataKi:  45.7nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM100822(US8507533, 399 | US8507533, 162 | US8507533, 129)
Affinity DataKi:  47.3nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM2229(US8507533, 448 | US8507533, 187)
Affinity DataKi:  47.8nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM142042(US8927577, 23)
Affinity DataKi:  50nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptor. Test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2015
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM100824(US8507533, 131)
Affinity DataKi:  51nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM142038(US8927577, 117 | US8927577, 32 | US8927577, 19)
Affinity DataKi:  53nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptor. Test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2015
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM100801(US8507533, 322 | US8507533, 109)
Affinity DataKi:  57.2nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM2387(US8507533, 143)
Affinity DataKi:  57.4nMAssay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM100826(US8507533, 133)
Affinity DataKi:  58nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM160583(US9045389, 18)
Affinity DataKi:  60nM ΔG°:  -38.3kJ/molepH: 7.4 T: 2°CAssay Description:Full-length human GCGR (Accession Number: NM000160) subcloned into pcDNA3.1 was stably transfected into HEK293 cells (hGluc-1 HEK) and maintained und...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2015
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM100831(US8507533, 144)
Affinity DataKi:  62.6nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM100829(US8507533, 140)
Affinity DataKi:  62.8nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM100847(US8507533, 163)
Affinity DataKi:  65.9nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM100797(US8507533, 105)
Affinity DataKi:  69.8nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM100799(US8507533, 107)
Affinity DataKi:  71.6nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM142038(US8927577, 117 | US8927577, 32 | US8927577, 19)
Affinity DataKi:  74nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptor. Test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2015
Entry Details
Go to US Patent

Displayed 1 to 50 (of 128 total ) | Next | Last >>
Jump to: